| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vericel Corp | Director | Common Stock | 15,100 | $582,709 | $38.59 | 10 Nov 2025 | Direct |
| Invivyd, Inc. | Director | Common Stock | 50,000 | $125,000 | $2.50 | 19 Nov 2025 | Direct |
| Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50,000 | 20 May 2025 | Direct | ||
| Vericel Corp | Director | Stock Option (Right to Buy) | 10,500 | 10 Nov 2025 | Direct | ||
| Vericel Corp | Director | Restricted Stock Unit | 3,200 | 30 Apr 2025 | Direct | ||
| ACCELERON PHARMA INC | SVP, CFO and Treasurer | Common Stock | 0 | $175.00 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | SVP, CFO and Treasurer | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct | ||
| Decibel Therapeutics, Inc. | Director | Common Stock | 0 | $5.03 | 25 Sep 2023 | Direct | |
| Decibel Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 25 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | 19 Nov 2025 | 1 | +$125,000 | 4 | Director | 20 Nov 2025, 16:22 |
| VCEL | Vericel Corp | 10 Nov 2025 | 3 | -$251,720 | 4 | Director | 12 Nov 2025, 16:06 |
| VCEL | Vericel Corp | 06 Aug 2025 | 3 | -$232,120 | 4 | Director | 08 Aug 2025, 16:05 |
| IVVD | Invivyd, Inc. | 20 May 2025 | 1 | $0 | 4 | Director | 22 May 2025, 16:14 |
| VCEL | Vericel Corp | 07 May 2025 | 3 | -$260,540 | 4 | Director | 09 May 2025, 16:05 |
| VCEL | Vericel Corp | 30 Apr 2025 | 4 | $0 | 4 | Director | 02 May 2025, 16:07 |
| VCEL | Vericel Corp | 12 Feb 2025 | 6 | -$363,050 | 4 | Director | 14 Feb 2025, 16:05 |
| VCEL | Vericel Corp | 13 Nov 2024 | 3 | -$362,600 | 4 | Director | 15 Nov 2024, 16:05 |
| VCEL | Vericel Corp | 07 Aug 2024 | 6 | -$295,400 | 4 | Director | 09 Aug 2024, 16:05 |
| IVVD | Invivyd, Inc. | 21 May 2024 | 1 | $0 | 4 | Director | 23 May 2024, 18:26 |
| IVVD | Invivyd, Inc. | 21 May 2024 | 0 | $0 | 3 | Director | 23 May 2024, 17:07 |
| VCEL | Vericel Corp | 01 May 2024 | 4 | $0 | 4 | Director | 03 May 2024, 16:06 |
| DBTX | Decibel Therapeutics, Inc. | 25 Sep 2023 | 3 | $0 | 4 | Director | 25 Sep 2023, 17:28 |
| DBTX | Decibel Therapeutics, Inc. | 13 Jun 2023 | 2 | $0 | 4 | Director | 14 Jun 2023, 16:37 |
| VCEL | Vericel Corp | 03 May 2023 | 2 | $0 | 4 | Director | 05 May 2023, 16:04 |
| VCEL | Vericel Corp | 27 Apr 2023 | 2 | $0 | 4 | Director | 28 Apr 2023, 16:04 |
| DBTX | Decibel Therapeutics, Inc. | 10 Oct 2022 | 1 | $0 | 4 | Director | 12 Oct 2022, 08:23 |
| DBTX | Decibel Therapeutics, Inc. | 10 Oct 2022 | 0 | $0 | 3 | Director | 12 Oct 2022, 08:13 |
| VCEL | Vericel Corp | 27 Apr 2022 | 4 | $0 | 4 | Director | 29 Apr 2022, 16:10 |
| XLRN | ACCELERON PHARMA INC | 19 Nov 2021 | 6 | $0 | 4 | SVP, CFO and Treasurer | 22 Nov 2021, 08:03 |
| XLRN | ACCELERON PHARMA INC | 23 Sep 2021 | 13 | -$3,011,252 | 4 | SVP, CFO and Treasurer | 24 Sep 2021, 19:36 |